STOCK TITAN

Exact Sciences Schedules Fourth Quarter 2024 Earnings Call

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

Exact Sciences (Nasdaq: EXAS) has announced it will release its fourth quarter 2024 financial results after U.S. market close on February 19, 2025. The company will host a webcast and conference call at 5 p.m. ET on the same day to discuss the results and business progress.

Interested parties can access the live webcast at www.exactsciences.com. For the conference call, domestic callers should dial 888-330-2384, while international callers can use +1 240-789-2701. The access code for all callers is 4437608. A replay of the webcast will be available on the company's website.

Exact Sciences (Nasdaq: EXAS) ha annunciato che rilascerà i suoi risultati finanziari del quarto trimestre 2024 dopo la chiusura del mercato statunitense il 19 febbraio 2025. L'azienda ospiterà un webcast e una conferenza telefonica alle 17.00 ET lo stesso giorno per discutere i risultati e i progressi aziendali.

Le parti interessate possono accedere al webcast dal vivo su www.exactsciences.com. Per la conferenza telefonica, i chiamanti domestici devono comporre il numero 888-330-2384, mentre i chiamanti internazionali possono utilizzare il numero +1 240-789-2701. Il codice di accesso per tutti i chiamanti è 4437608. Una registrazione del webcast sarà disponibile sul sito web dell'azienda.

Exact Sciences (Nasdaq: EXAS) ha anunciado que publicará sus resultados financieros del cuarto trimestre de 2024 después del cierre del mercado estadounidense el 19 de febrero de 2025. La compañía llevará a cabo un webcast y una llamada de conferencia a las 5 p.m. ET el mismo día para discutir los resultados y los avances comerciales.

Las partes interesadas pueden acceder al webcast en vivo en www.exactsciences.com. Para la llamada de conferencia, los llamantes nacionales deben marcar el 888-330-2384, mientras que los llamantes internacionales pueden usar +1 240-789-2701. El código de acceso para todos los llamantes es 4437608. Una grabación del webcast estará disponible en el sitio web de la empresa.

엑잭트 사이언시스(Exact Sciences) (Nasdaq: EXAS)는 2024년 4분기 재무 결과를 미국 시장 마감 후 2025년 2월 19일에 발표할 것이라고 발표했습니다. 회사는 같은 날 오후 5시 ET에 결과 및 사업 진행에 대해 논의하기 위해 웹캐스트와 전화 회의를 개최할 예정입니다.

관심 있는 분들은 www.exactsciences.com에서 라이브 웹캐스트에 접속할 수 있습니다. 전화 회의를 위해 국내 호출자는 888-330-2384로 전화해야 하며, 국제 호출자는 +1 240-789-2701을 사용할 수 있습니다. 모든 호출자의 액세스 코드는 4437608입니다. 웹캐스트의 재생은 회사 웹사이트에서 제공됩니다.

Exact Sciences (Nasdaq: EXAS) a annoncé qu'elle publiera ses résultats financiers du quatrième trimestre 2024 après la fermeture des marchés américains le 19 février 2025. L'entreprise organisera un webcast et une conférence téléphonique à 17h00 ET le même jour pour discuter des résultats et des avancées commerciales.

Les parties intéressées peuvent accéder au webcast en direct sur www.exactsciences.com. Pour la conférence téléphonique, les appelants nationaux doivent composer le 888-330-2384, tandis que les appelants internationaux peuvent utiliser le +1 240-789-2701. Le code d'accès pour tous les appelants est 4437608. Un replay du webcast sera disponible sur le site Web de l'entreprise.

Exact Sciences (Nasdaq: EXAS) hat angekündigt, dass es seine Finanzergebnisse für das vierte Quartal 2024 nach dem US-Marktschluss am 19. Februar 2025 veröffentlichen wird. Das Unternehmen wird am selben Tag um 17:00 Uhr ET ein Webcast und eine Telefonkonferenz abhalten, um die Ergebnisse und den Geschäftsfortschritt zu besprechen.

Interessierte Parteien können den Live-Webcast unter www.exactsciences.com abrufen. Für die Telefonkonferenz sollten nationale Anrufer die Nummer 888-330-2384 wählen, während internationale Anrufer +1 240-789-2701 verwenden können. Der Zugangs-Code für alle Anrufer lautet 4437608. Eine Wiederholung des Webcasts wird auf der Website des Unternehmens verfügbar sein.

Positive
  • None.
Negative
  • None.

MADISON, Wis.--(BUSINESS WIRE)-- Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the company plans to release its fourth quarter 2024 financial results after the close of the U.S. financial markets on February 19, 2025. Following the release, company management will host a webcast and conference call at 5 p.m. ET to discuss financial results and business progress.

Fourth quarter 2024 webcast & conference call details

Date: 

 

Wednesday, February 19, 2025

Time: 

 

5 p.m. ET

Webcast: 

 

The live webcast can be accessed at www.exactsciences.com

Telephone: 

 

Domestic callers, dial 888-330-2384 

 

 

International callers, dial +1 240-789-2701

           

 

Access code for both domestic and international callers: 4437608

 A replay of the webcast will be available at www.exactsciences.com. The webcast, conference call, and replay are open to all interested parties.

About Exact Sciences Corp.

A leading provider of cancer screening and diagnostic tests, Exact Sciences gives patients and health care professionals the clarity needed to take life-changing action earlier. Building on the success of the Cologuard® and Oncotype® tests, Exact Sciences is investing in its pipeline to develop innovative solutions for use before, during, and after a cancer diagnosis. For more information, visit ExactSciences.com, follow Exact Sciences on X @ExactSciences, or find Exact Sciences on LinkedIn and Facebook.

Erik Holznecht

Exact Sciences Corp.

investorrelations@exactsciences.com

608-800-6605

Source: Exact Sciences Corp.

FAQ

When will Exact Sciences (EXAS) report Q4 2024 earnings?

Exact Sciences will report its Q4 2024 earnings after market close on February 19, 2025.

How can investors join Exact Sciences' (EXAS) Q4 2024 earnings call?

Investors can join via webcast at www.exactsciences.com or by phone: 888-330-2384 (domestic) or +1 240-789-2701 (international) using access code 4437608.

What time is Exact Sciences' (EXAS) Q4 2024 earnings call?

The earnings call is scheduled for 5 p.m. ET on February 19, 2025.

Will there be a replay available for Exact Sciences' (EXAS) Q4 2024 earnings call?

Yes, a replay of the webcast will be available at www.exactsciences.com.

Exact Sciences Corp

NASDAQ:EXAS

EXAS Rankings

EXAS Latest News

EXAS Stock Data

10.00B
182.39M
1.02%
101.67%
5.56%
Diagnostics & Research
Services-medical Laboratories
Link
United States of America
MADISON